Neurocrine Biosciences (NBIX) FCF Margin Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 253.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1,444.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,941.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,671.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1,067.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -42,016.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 895.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 830.00 |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 22,587.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,671.00 |
| Dec 31, 2025 | 1,320.00 |
| Sep 30, 2025 | 195.00 |
| Jun 30, 2025 | -63,348.00 |
| Mar 31, 2025 | 2,493.00 |
| Dec 31, 2024 | 3,209.00 |
| Sep 30, 2024 | 737.00 |
| Jun 30, 2024 | -2,925.00 |
| Mar 31, 2024 | -992.00 |
| Dec 31, 2023 | -2,148.00 |
| Sep 30, 2023 | 5,541.00 |
| Jun 30, 2023 | -303.00 |
| Mar 31, 2023 | -4,435.00 |
| Dec 31, 2022 | -792.00 |
| Sep 30, 2022 | -1,294.00 |
| Jun 30, 2022 | 61,576.00 |
| Mar 31, 2022 | 6,623.00 |
| Dec 31, 2021 | -2,845.00 |
| Sep 30, 2021 | -2,055.00 |
| Jun 30, 2021 | 2,018.00 |